Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIcg-longbow Regulatory News (LBOW)

Share Price Information for Icg-longbow (LBOW)

Share Price is delayed by 15 minutes
Get Live Data
13.00    0.00 (0.00%)
Bid:
11.10
Ask:
14.90
Spread: 3.80 (34.234%)
Market Cap: £15.77m
LBOW Live PriceLast checked at - London Stock Exchange

Intraday Icg-longbow Share Chart

Portfolio Update

9 Sep 2019 07:00

RNS Number : 5793L
ICG-Longbow Snr Sec UK Prop DebtInv
09 September 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN.

 

9 September 2019

ICG-Longbow Senior Secured UK Property Debt Investments Limited (the Company)

Portfolio Update

 

 

The Company has entered into a new £24.6 million loan commitment to an affiliate of RoyaleLife, the UK's leading provider of bungalow homes. The Company is participating in a larger £142.7 million loan facility alongside two other funds managed by the Investment Adviser, in line with the Company's investment criteria.

 

The loan will refinance a portfolio of 10 assets in the residential bungalow homes sector. It carries a four-year term and has an initial LTV ratio of 78.9%. Day 1 drawings on the loan will be approximately £20.3 million, with the Company also providing a committed capital expenditure facility in support of the borrower's business plan.

 

On completion, the Company's total invested capital will be £112.5 million with undrawn follow-on commitments of £10.3 million. Portfolio LTV will be 62.5% with a weighted average loan duration of approximately 2.1 years. The RoyaleLife loan is accretive for shareholders, with the Company's pro forma weighted average interest coupon rising to 7.06%. In addition, the loan contains significant contracted exit fees which further boost the returns from the transaction.

 

The Company is currently executing a further circa £15.3 million hotel investment and circa £6.5 million office investment which it expects to sign in the coming weeks. In order to finance the RoyaleLife transaction and this immediate pipeline, the Company has drawn down £10 million on its revolving credit facility.

 

As highlighted in previous updates, upon closing these investments the Company's cash will be fully committed with the revolving credit facility largely drawn. It is anticipated that drawings under the revolving credit facility will be repaid in due course from the issuance of new shares and/or funds received from portfolio redemptions.

 

The Company is pleased to note that, upon completion of these investments, full dividend cover will be restored.

 

 

For further information please contact:

Estera International Fund Managers (Guernsey) Limited:

Louise Manklow

 

+44 (0)14 8174 2783

Cenkos Securities:

Will Rogers

Alex Collins

 

+44 (0)20 7397 1920

+44 (0)20 7397 1913

 

Maitland Consultancy Limited:

Rebecca Mitchell

+44 (0)20 7379 5151

 

ICG-Longbow

Martin Wheeler

David Mortimer

 

+44 (0)20 3201 7502

+44 (0)20 3201 7532

 

Further information on the Company can be found on its website at http://www.lbow.co.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFULIFEAAEIDIIA
Date   Source Headline
1st Apr 202210:44 amRNSDirector/PDMR Shareholding
29th Mar 20224:33 pmRNSDirector/PDMR Shareholding
28th Mar 20229:05 amRNSDirector/PDMR Shareholding
24th Mar 20227:01 amRNSInterim Dividend Announcement
24th Mar 20227:00 amRNSQuarterly Update
7th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSDirector Declaration
18th Feb 20224:41 pmRNSSecond Price Monitoring Extn
18th Feb 20224:35 pmRNSPrice Monitoring Extension
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
11th Jan 20224:01 pmRNSReturn of Capital and NAV
20th Dec 20211:01 pmRNSPortfolio Update
9th Dec 20217:00 amRNSQuarterly Update
7th Dec 20217:01 amRNSInterim Dividend Announcement
7th Dec 20217:00 amRNSReturn of Capital and NAV
29th Nov 20217:00 amRNSPortfolio Update
18th Oct 20217:00 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSDirector/PDMR Shareholding
12th Oct 20214:07 pmRNSDirector/PDMR Shareholding
6th Oct 20215:24 pmRNSDirector/PDMR Shareholding
30th Sep 20217:01 amRNSHalf-Year Report
30th Sep 20217:00 amRNSInterim Dividend Announcement
23rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:35 pmRNSPrice Monitoring Extension
14th Sep 20217:00 amRNSQuarterly Update
13th Sep 202110:14 amRNSReturn of Capital and NAV
5th Aug 20218:36 amRNSPortfolio Update
28th Jun 20216:26 pmRNSInterim Dividend Declaration - Replacement
28th Jun 20213:08 pmRNSDirectorate Change
28th Jun 20213:06 pmRNSResult of AGM
28th Jun 20211:41 pmRNSDividend Declaration
17th Jun 20217:00 amRNSQuarterly Update
12th May 202110:25 amRNSDirector/PDMR Shareholding
10th May 202110:03 amRNSNotice of AGM
10th May 20217:00 amRNSAnnual Report for the year ended 31 January 2021
24th Mar 20213:42 pmRNSInterim Dividend Declaration
16th Mar 20217:00 amRNSQuarterly Update
14th Jan 20213:45 pmRNSResults of Extraordinary General Meeting
13th Jan 20217:00 amRNSPortfolio Update
16th Dec 20207:00 amRNSCircular & Notice of Extraordinary General Meeting
11th Dec 20205:27 pmRNSCommittee Appointments
11th Dec 20207:00 amRNSInterim Dividend Announcement
8th Dec 20207:00 amRNSQuarterly Update
25th Nov 20207:00 amRNSChange of Management Arrangements
12th Nov 20207:00 amRNSPortfolio Update
3rd Nov 20207:00 amRNSOrderly Realisation and Return of Capital
21st Oct 20207:00 amRNSPortfolio Update
20th Oct 20206:00 pmRNSDirector/PDMR Shareholding
12th Oct 20203:41 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.